期刊文献+

悬浮芯片检测血清HIF-1α和Her-2水平对于乳腺癌的诊断价值 被引量:1

The value of the contents of serum HIF-1α and Her-2 detected by suspension array in the diagnosis of breast cancer
下载PDF
导出
摘要 目的:探讨乳腺癌血清中HIF-1α和Her-2的表达水平、二者相关性及其对乳腺癌临床诊断的价值。方法:悬浮芯片法检测117例乳腺原发癌、10例复发乳腺癌、20例乳腺良性肿瘤和31例正常人血清HIF-1α和Her-2含量。结果:原发、复发乳腺癌血清HIF-1α和Her-2水平高于良性肿瘤和正常人(P<0.01),复发乳腺癌高于原发乳腺癌(P<0.05),良性肿瘤和正常人血清中HIF-1α和Her-2的水平无统计学差异(P>0.05);不同病理类型组内血清HIF-1α和Her-2含量有统计学差异(P<0.05);乳腺癌患者血清HIF-1α和Her-2的水平呈正相关(P=0.00)。结论:血清HIF-1α和Her-2能准确反映乳腺癌的生物学特性,是评估乳腺癌患者预后的重要指标。 Objective To explore the expression Of hypoxia induced factor -1α(HIF-1α) and Her-2 in the serum of breast cancer, and the relationship between the two as well as its value in clinical diagnose of breast cancer. Method Suspension array was used to test the content of serum HIF-1α and Her-2 in 117 cases of original breast can-cer, 10 cases of recurrent breast cancer, 20 cases of benign breast tumor and 31 healthy people. Result The expressions of serum HIF-1α and Her-2 in original and recurrent breast cancer are obviously higher than benign tumor and healthy people (P 〈 0.01 ). Recurrent breast cancer is significantly higher than original ones (P 〈 0.05). No statistically differences in either HIF-1α or Her-2 were found between benign tumor and healthy people (P 〉 0.05). The expression of serum HIF-1α and Her-2 goes up with the increasing rate of the different stages of breast, cancer, histological grade, the size of tumor. It increases with lymph node metastasis (P 〈 0.01 ) with sortie gaps in statistics within the group (P 〈 0.05). The positive correlation between the expression of HIF-1α and Her-2 was observed in the patients of breast cancer (P = 0.00). Conclusion Serum HIF-1α and Her-2 may accurately reflect the biological characteristics of breast eaneer and play an important role in evaluating prognosis.
出处 《实用医学杂志》 CAS 北大核心 2011年第11期1947-1950,共4页 The Journal of Practical Medicine
基金 宁波市医学科技计划项目(编号:2007013)
关键词 乳腺肿瘤 HIF-1Α HER-2 悬浮芯片 Breast cancer HIF-1α Her-2 Suspension array
  • 相关文献

参考文献11

  • 1Zhong H, De Matzo A M, Laughner E, et al. Over expression of hypoxia-inducible factor 1 in common human cancers and their metastases [J]. Cancer Res, 1999,59(22) :5830-5835.
  • 2Hayes Daniel F, Thor Ann D. c-erbB-2 in breast cancer: development of a clinically useful marker [J~. Semin Oncol, 2002,29(3) :231-145.
  • 3黄玉宝,叶长生,丁贵坡,黎相照.表皮生长因子受体和血管内皮生长因子在乳腺癌中的表达及临床意义[J].实用医学杂志,2008,24(10):1710-1712. 被引量:5
  • 4方芳,吴佩,茆家定,张帆,陈剑平.乳腺癌腋淋巴结转移影响因素分析[J].实用医学杂志,2009,25(16):2675-2676. 被引量:6
  • 5Bos R, vander Groep P, Greijer A E, et al. Levels of hypoxia-inducible factor-alpha independently predict prognosis in patients with lymph node negative breast carcinoma [J]. Cancer, 2003,97(6) : 1573-1581.
  • 6Kim K K, Lee J J, Yang Y, et al. Macrophage inhibitory cytokine-1 activates AKT and ERK-1/2 via the transactivation of ErbB2 in human breast and gastric cancer cells [J]. Carcinogenesis, 2008,29(4) :704-712.
  • 7Li Y M, Zhou B P, Deng J, et al. A hypoxia- independent6202hypoxia-inducible factor-1 activation pathway induced by phosphatidylinositol-3 kinase/Akt in HER2 overexpressing cells [J ]. Cancer Res, 200565 (8) : 3257-3263.
  • 8Matsumoto K, Arao T, Tanaka K, et al. mTOR signal and hypoxia-inducible factor-1 alpha regulate CD133 expression in8-Azaguaninecancer cells [J]. Cancer Res, 2009,69 (18) : 7160-7164.
  • 9Liu M, Howes A, Lesperance J, Antitumor activity of rapamycin in a transgenic mouse model of ErbB2-dependent human breast cancer [J]. Cancer Res, 2005,65 (12) : 5325- 5336.
  • 10Chen H H, Su W C. Hypoxia-indueible factor-lcdpha correlates with MET and metastasis in node-negative breast cancer [J]. Breast Cancer Res Treat, 2007,103(2) : 167-175.

二级参考文献27

  • 1孙治君,周鑫,姚榛祥,管小琴,李圆圆.P-gp、nm23和p53联合检测判断乳腺癌预后的价值[J].中国普外基础与临床杂志,2005,12(3):244-248. 被引量:9
  • 2李占文,李振平,胡云锵,杨华峰,刘纯,贺亚娟.176例Ⅱ、Ⅲ期乳腺癌腋淋巴结转移临床病理相关因素分析[J].临床外科杂志,2005,13(5):282-284. 被引量:11
  • 3毕晔,边莉,黄椠,郑刚,岳金波,左文述.我国乳腺癌热点问题研究的现状分析[J].中华肿瘤防治杂志,2006,13(16):1205-1211. 被引量:34
  • 4孙强.乳腺癌的早期诊断[J].实用医学杂志,2007,23(1):1-3. 被引量:77
  • 5Fogarty P, O'Beime B, Casey C. Epidemiology of the most frequent diseases in the European a-symptomatic post-menopausal women. Is there any difference between Ireland and the rest of Europe [J] ? Maturitas, 2005,52(Suppl 1 ) : S3-S6.
  • 6Hill T D, Khamis H J, Tyczynski J E, et al. Comparison of male and female breast cancer incidence trends, tumor characteristics, and survival [J]. Ann Epidemiol, 2005,15(10) :773-780.
  • 7Jatoi I. Management of the axilla in primary breast cancer [J]. Surg Clin North Am, 1999,79(5) : 1061-1073.
  • 8Silverstein M J, Skinner K A, Lomis T J. Predictihg axiUary nodal positivity in 2282 patients with breast carcinoma[J]. World J Surg, 2001,25(6) :767-772.
  • 9Korkolis D, Ardavanis A, Yotis J, et al. HER-2/neu overexpression in breast cancer: an immunohistochemical study including correlations with clinicopathologic parameters, p53 oncoprotein and cathepsin-D [J]. Anticancer Res, 2001,21 (3C) : 2207-2212.
  • 10刘复生.中国肿瘤病理学分类[M].北京:科学技术文献出版社,2001.225-226.

共引文献9

同被引文献17

  • 1Jemal A, Siegel R, Ward E, et al. Cancer statistics [ J ]. CA Cancer J Clin, 2009, 59:225-249.
  • 2Lin H, Balic M, Zheng S, et al. Disseminated and circulating tumor ceils : role in effective cancer management [ J ]. Crit Rev Oncol Hematol, 2011, 77:1-11.
  • 3Song HZ, Xu B, Yi J. Clinical significance of stanniocalcin-1 detected in peripheral blood and bone marrow of esophageal squamous cell carcinoma patients [ J ]. J Exp Clin Cancer Res, 2012, 26:31-35.
  • 4Nguyen A, Chang AC, Reddel RR. Stanniocalcin-1 acts in a negative feedback loop in the prosurvival ERK1/2 signaling path- way during oxidative stress [ J ]. Oncogene, 2009, 28. 1982-1992.
  • 5He LF, Wang TT, Gao QY, et al. Stanniocalcin-1 promotes tumor angiogenesis through up-regulation of VEGF in gastric cancer cells[J]. J Biomed Sci, 2011, 18:39.
  • 6Tamura S, Oshima T, Yoshihara K, et al. Clinical significance of STC1 gene expression in patients with colorectal cancer[ J]. Anticancer Res ,2011, 31:325-329.
  • 7Holmes DI, Zachary IC. Vascular endothelial growth factor regu- lates stanniocalcin-1 expression via neuropilin-1-dependent regu- lation of KDR and synergism with fibroblast growth factor-2 [ J]. Cell Signal, 2008, 20:569-579.
  • 8Law AY, Lai KP, Lui WC, et al. Histone deacetylase inhibitor- induced cellular apoptosis involves stanniocalcin-1 activation [ J ] . Exp Cell Res, 2008, 314:2975-2984.
  • 9FJoensuu K, Heikkila P, Andersson LC. Tumor dormancy : ele- vated expression of stanniocalcins in late relapsing breast cancer [J]. Cancer Letters, 2008, 265:76-83.
  • 10Rey S, Semenza GL Hypoxia-inducible factor-1-dependent mechanisms of vascularization and vascular remodelling [ J ]. Cardiovase Res, 2010, 86:236-242.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部